Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Glomerulonephritis, Membranous

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Glomerulonephritis, Membranous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aiello, S; Benfenati, E; Benigni, A; Boccardo, P; Gotti, E; Noris, M; Remuzzi, G; Todeschini, M1
Horie, M; Mase, T; Nagaoka, H; Sakurai, Y; Tomioka, K; Yamada, T1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Glomerulonephritis, Membranous

ArticleYear
Urinary excretion of platelet activating factor in patients with immune-mediated glomerulonephritis.
    Kidney international, 1993, Volume: 43, Issue:2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Female; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Neutrophils; Phospholipases A; Platelet Activating Factor; Proteinuria

1993
Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.
    Biochemical and biophysical research communications, 1991, Apr-30, Volume: 176, Issue:2

    Topics: Animals; Azepines; Disease Models, Animal; Glomerulonephritis, Membranous; Hypercholesterolemia; Male; Metabolic Clearance Rate; Methylprednisolone; Piperazines; Platelet Activating Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Ticlopidine; Triazoles

1991